Admission to Main Market

Further to the announcement on 24 June 2025, Elixirr International plc (AIM:ELIX) ("Elixirr", the "Company" or, together with its subsidiary undertakings, the "Group"), an established, global award-winning challenger consultancy, is pleased to announce that its ordinary shares (the "Ordinary Shares") will be admitted to listing on the Equity Shares (Commercial Companies) Category of the Official List of the Financial Conduct Authority and to trading on the Main Market for listed securities of the London Stock Exchange (together, "Admission") at 8.00 a.m. today and, accordingly, will be cancelled from trading on AIM.

Elixirr is not offering any new Ordinary Shares nor any other securities in connection with Admission. Following Admission, the Ordinary Shares will continue to be registered with their existing ISIN of GB00BLPHTX84 and the TDIM will remain ELIX.

The Company's shareholders should consult their own professional advisers regarding the consequences of Admission for them.

Stephen Newton, Founder and CEO of Elixirr, commented:

"Since our IPO in 2020, we've delivered consistent growth, expanded our global footprint, and strengthened our position as the Challenger Consultancy. This move reflects our continued ambition to scale the business, access a broader investor base, and reinforce our long-term commitment to building the best consultancy in the world. I'm immensely proud of what we've achieved so far and excited for what lies ahead."